Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection

NCT00305227 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Urinary Tract Infection

Interventions

DRUG: Lactin-V
DRUG: Placebo

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]